# António Gil‐Nagel

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/antonio-gil-nagel/

## Facts

| Field | Value |
| --- | --- |
| Citations | 9,371 |
| Field | Epilepsy research and treatment |
| h-index | 46 |
| i10-index | 124 |
| Last Known Institution | Hospital Ruber Internacional |
| OpenAlex ID | https://openalex.org/A5026329899 |
| ORCID iD | 0000-0003-4515-0793 |
| Works | 264 |

## Researcher papers

- [Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery](https://scholariq.org/papers/histopathological-findings-in-brain-tissue-obtained-during-epilepsy-surgery/)
- [Unified Parkinson's disease rating scale characteristics and structure](https://scholariq.org/papers/unified-parkinson-s-disease-rating-scale-characteristics-and-structure/)
- [A fast pathway for fear in human amygdala](https://scholariq.org/papers/a-fast-pathway-for-fear-in-human-amygdala/)
- [Mutations in the Gene Encoding KRIT1, a Krev-1/rap1a Binding Protein, Cause Cerebral Cavernous Malformations (CCM1)](https://scholariq.org/papers/mutations-in-the-gene-encoding-krit1-a-krev-1-rap1a-binding-protein-cause/)
- [Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study](https://scholariq.org/papers/seizure-outcome-and-use-of-antiepileptic-drugs-after-epilepsy-surgery-according/)
- [Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome](https://scholariq.org/papers/dose-ranging-effect-of-adjunctive-oral-cannabidiol-vs-placebo-on-convulsive/)
- [Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens](https://scholariq.org/papers/fenfluramine-for-treatment-resistant-seizures-in-patients-with-dravet-syndrome/)
- [Epidemiological profile of epilepsy in low income populations](https://scholariq.org/papers/epidemiological-profile-of-epilepsy-in-low-income-populations/)
- [Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy](https://scholariq.org/papers/efficacy-and-safety-of-adjunctive-ezogabine-retigabine-in-refractory-partial/)
- [Ictal semiology in hippocampal versus extrahippocampal temporal lobe epilepsy](https://scholariq.org/papers/ictal-semiology-in-hippocampal-versus-extrahippocampal-temporal-lobe-epilepsy/)
- [Fenfluramine Increases Seizure-Free Days in Patients With Lennox–Gastaut Syndrome](https://scholariq.org/papers/fenfluramine-increases-seizure-free-days-in-patients-with-lennox-gastaut/)

## Researcher topics

- [Epilepsy research and treatment](https://scholariq.org/topics/epilepsy-research-and-treatment/)
- [Pharmacological Effects and Toxicity Studies](https://scholariq.org/topics/pharmacological-effects-and-toxicity-studies/)
- [Neuroscience and Neuropharmacology Research](https://scholariq.org/topics/neuroscience-and-neuropharmacology-research/)
- [EEG and Brain-Computer Interfaces](https://scholariq.org/topics/eeg-and-brain-computer-interfaces/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)

## Researcher university

- [Hospital Ruber Internacional](https://scholariq.org/institutions/hospital-ruber-internacional/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.